These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38255406)

  • 21. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening.
    Munck A; Mayell SJ; Winters V; Shawcross A; Derichs N; Parad R; Barben J; Southern KW;
    J Cyst Fibros; 2015 Nov; 14(6):706-13. PubMed ID: 25630966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability of the sweat test in children with Cystic Fibrosis previously CRMS/CFSPID: A retrospective monocenter experience.
    Terlizzi V; Dolce D
    J Cyst Fibros; 2023 May; 22(3):496-498. PubMed ID: 37117083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic challenges in CFTR-related metabolic syndrome: Where the guidelines fall short.
    Kallam EF; Kasi AS; Barr E; Linnemann RW; Guglani L
    Paediatr Respir Rev; 2024 Mar; 49():28-33. PubMed ID: 37659865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel insights into the diagnostic and therapeutic challenges of the CFTR metabolic syndrome/CF screen positive indeterminate diagnosis.
    Machogu E; Ren CL
    Pediatr Pulmonol; 2016 Oct; 51(S44):S45-S48. PubMed ID: 27662103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal Lung Clearance Index in Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) Children with Otherwise Normal FEV
    Kasi AS; Wee CP; Keens TG; Salinas DB
    Lung; 2020 Feb; 198(1):163-167. PubMed ID: 31844968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'We're kind of like genetic nomads': Parents' experiences of biographical disruption and uncertainty following in/conclusive results from newborn cystic fibrosis screening.
    Boardman F; Clark C
    Soc Sci Med; 2022 May; 301():114972. PubMed ID: 35430463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inconclusive diagnosis of cystic fibrosis after newborn screening.
    Ooi CY; Castellani C; Keenan K; Avolio J; Volpi S; Boland M; Kovesi T; Bjornson C; Chilvers MA; Morgan L; van Wylick R; Kent S; Price A; Solomon M; Tam K; Taylor L; Malitt KA; Ratjen F; Durie PR; Gonska T
    Pediatrics; 2015 Jun; 135(6):e1377-85. PubMed ID: 25963003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosis.
    Terlizzi V; Claut L; Colombo C; Tosco A; Castaldo A; Fabrizzi B; Lucarelli M; Cimino G; Carducci C; Dolce D; Biffi A; Bonomi P; Timpano S; Padoan R
    Pediatr Pulmonol; 2021 Dec; 56(12):3785-3791. PubMed ID: 34549893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study.
    Johnson F; Southern KW; Ulph F
    Int J Neonatal Screen; 2019 Jun; 5(2):23. PubMed ID: 33072982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening.
    Ren CL; Fink AK; Petren K; Borowitz DS; McColley SA; Sanders DB; Rosenfeld M; Marshall BC
    Pediatrics; 2015 Jun; 135(6):e1386-92. PubMed ID: 25963008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor.
    Patel P; Yeley J; Brown C; Wesson M; Lesko BG; Slaven JE; Chmiel JF; Jain R; Sanders DB
    Int J Neonatal Screen; 2023 Feb; 9(1):. PubMed ID: 36975847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between Gibson-Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis.
    Dolce D; Fevola C; Camera E; Orioli T; Lucenteforte E; Malanima MA; Taccetti G; Terlizzi V
    Int J Neonatal Screen; 2023 Jul; 9(3):. PubMed ID: 37606478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.
    Gonska T; Keenan K; Au J; Dupuis A; Chilvers MA; Burgess C; Bjornson C; Fairservice L; Brusky J; Kherani T; Jober A; Kosteniuk L; Price A; Itterman J; Morgan L; Mateos-Corral D; Hughes D; Donnelly C; Smith MJ; Iqbal S; Arpin J; Reisman J; Hammel J; van Wylick R; Derynck M; Henderson N; Solomon M; Ratjen F
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience.
    Şaşihüseyinoğlu AŞ; Altıntaş DU; Bişgin A; Doğruel D; Yılmaz M; Serbes M
    Turk J Pediatr; 2019; 61(4):505-512. PubMed ID: 31990467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parental Preferences about Policy Options Regarding Disclosure of Incidental Genetic Findings in Newborn Screening: Using Videos and the Internet to Educate and Obtain Input.
    Farrell MH; Mooney KE; Laxova A; Farrell PM
    Int J Neonatal Screen; 2022 Sep; 8(4):. PubMed ID: 36278624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of fecal elastase improves performance of newborn screening for cystic fibrosis.
    Barben J; Rueegg CS; Jurca M; Spalinger J; Kuehni CE;
    J Cyst Fibros; 2016 May; 15(3):313-7. PubMed ID: 26826912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When CFSPID becomes CF.
    Ginsburg D; Wee CP; Reyes MC; Brewington JJ; Salinas DB
    J Cyst Fibros; 2022 Jan; 21(1):e23-e27. PubMed ID: 34756682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-pulmonary CFTR-related symptom improvement with ivacaftor in p.Phe508del/p.Arg117His (7T) cystic fibrosis.
    Kuek SL; Massie RJH
    Respirol Case Rep; 2023 Jan; 11(1):e01079. PubMed ID: 36569635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.